# Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21)

> **NCT06390124** · PHASE4 · COMPLETED · sponsor: **Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain** · enrollment: 11 (actual)

## Conditions studied

- Peri-Implantitis

## Interventions

- **DRUG:** Platelet Derived Growth Factor (PDGF)

## Key facts

- **NCT ID:** NCT06390124
- **Lead sponsor:** Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06390124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06390124, "Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06390124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*